Dongjin Semichem Co., Ltd. (KOSDAQ:005290)
43,750
-1,050 (-2.34%)
Jul 14, 2026, 3:30 PM KST
Dongjin Semichem Revenue
Dongjin Semichem had revenue of 328.09B KRW in the quarter ending March 31, 2026, with 13.22% growth. This brings the company's revenue in the last twelve months to 1.23T, up 15.22% year-over-year. In the year 2025, Dongjin Semichem had annual revenue of 1.19T with 7.31% growth.
Revenue (ttm)
1.23T
Revenue Growth
+15.22%
P/S Ratio
1.85
Revenue / Employee
941.52M
Employees
1,309
Market Cap
2.28T
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.19T | 81.33B | 7.31% |
| Dec 31, 2024 | 1.11T | -197.11B | -15.05% |
| Dec 31, 2023 | 1.31T | -147.29B | -10.11% |
| Dec 31, 2022 | 1.46T | 295.93B | 25.48% |
| Dec 31, 2021 | 1.16T | 223.48B | 23.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Partron | 1.47T |
| Shinsung Delta Tech | 962.54B |
| MNtech | 494.37B |
| WiSoL CO.,LTD. | 333.03B |
| Synopex | 251.52B |
| Fine M-Tec CO.,LTD. | 241.61B |
| Sang-A Frontec | 203.78B |
| UJU Electronics Co. | 186.21B |
Dongjin Semichem News
- 6 weeks ago - Dongjin Semichem Slides: Investor presentation - Filings
- 2 months ago - Dongjin Semichem Quarterly report: Q1 2026 - Filings
- 3 months ago - Dongjin Semichem Slides: Investor presentation - Filings
- 4 months ago - Dongjin Semichem Annual report: Q4 2025 - Filings
- 8 months ago - Dongjin Semichem Quarterly report: Q3 2025 - Filings
- 11 months ago - Dongjin Semichem Quarterly report: Q2 2025 - Filings